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Abstract
BACKGROUND: Encephalitis is a serious condition that contains neurological dysfunction cause by inflammation of 
the brain tissue. Etiological factors for the occurrence of this condition include infectious and non-infectious causes.
CASE REPORT: We are presented 9-month-old infant referred to our clinic in convulsive status, fever, and disturbed 
consciousness. From anamnestic information, the infant has been febrile for 2 days with profuse vomiting initiating just 
before admission at the clinic. At the moment of admission in the clinic, the infant looked intoxicated with generalized 
tonic-clonic seizures, with shortness of breath and fever with a weakened reaction to painful stimuli. It was admitted 
in the Isolation Unit by the protocol of the clinic. Laboratory investigations were done. Due to the persistence of 
convulsive status, a computed tomography scan of the brain was performed with the finding of enlargement of the 
lateral ventricles, with intraventricular masses and pronounced internal hydrocephalus. The results of severe acute 
respiratory syndrome coronavirus 2 (SARS-COV-2) from the infant were positive as well as the grandmother. The 
infant was intubated immediately and put on mechanical ventilation SIPPV.
CONCLUSION: Our case report could suggest that SARS-CoV-2 infection may cause severe clinical symptoms, 
neurological manifestations, and encephalitis in infants.
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Introduction
Encephalitis is a serious condition that 
contains neurological dysfunction cause by 
inflammation of the brain tissue [1]. Etiological 
factors for the occurrence of this condition include 
infectious and non-infectious causes [2], [3]. The 
exact cause of this condition is often unknown, but 
the most common causes of infection are viruses. The 
viruses that can cause encephalitis include Varicella-
Zoster virus, Epstein-Barr virus, Herpes simplex virus 
(type 1 and 2), enteroviruses, Rubeola, West Nile 
virus, and Rabies [2], [4]. Encephalitis can also be 
caused by a bacterial infection such as tuberculosis, 
syphilis, Lyme disease, or after an infection caused 
by parasites such as toxoplasmosis [5]. Non-
infectious causes include an autoimmune reaction 
in the body and this occurs when the body’s own 
immune system produces antibodies against brain 
tissue [6]. Diagnostic tests required to confirm the 
diagnosis include: Blood tests, BAL or sputum, urine 
and stool tests, electroencephalography, lumbar 
puncture, X-ray, computed tomography (CT) scan, 
and magnetic resonance imaging [7], [8]. Treatment 
of viral encephalitis consists of antiviral drugs, 
supportive therapy such as monitoring of cardiac 
and respiratory function and respiratory support, 
intravenous fluids, anti-inflammatory drugs, and 
anticonvulsant drugs [9], [10], [11].
Human coronaviruses (CoVs) can be found 
in human population, and they can cause respiratory, 
enteric, hepatic, and neurological diseases [12], [13]. 
A novel CoV first time appears in December 2019 in 
Wuhan, Hubei province of China, with severe pneumonia 
causes [14]. Severe acute respiratory syndrome CoV 
2 (SARS-CoV-2) is the third human CoV known to 
co-opt the peptidase angiotensin-converting enzyme 
2 (ACE2) for cell entry [15]. SARS-CoV-2 cell entry 
is dependent on its 180-kDa spike (S) protein, which 
mediates two essential events: Binding to ACE2 by the 
amino-terminal region and fusion of viral and cellular 
membranes through the carboxyl-terminal region [16]. 
Infection of lung cells requires host proteolytic activation 
of the spike at a polybasic furin cleavage site [17]. The 
lung pathology in severe disease is different from the 
earlier pneumonitis, with progressive loss of epithelial-
endothelial integrity, septal capillary injury, and marked 
neutrophil infiltration, with complement deposition, 
intravascular viral antigen deposition, and localized 
intravascular coagulation [18]. The virus binds to 
the ACE2 receptor, located in epithelium of the small 
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intestine, respiratory tract, kidney cells, respiratory tract, 
the vascular endothelium throughout the body, and 
widely throughout the central nervous systems. ACE2 
receptor is expressed in astrocytes, oligodendrocytes, 
neurons and concentrated in ventricles, and posterior 
cingulate cortex, olfactory bulb, substantia nigra, and 
middle temporal gyrus. Most patients with SARS-CoV-2 
manifest a respiratory infection followed by sore throat 
cough, fatigue, shortness of breath, and respiratory 
distress. In addition to these effects on organic systems, 
larger studies published by China and France show that 
as many as 36% of patients with this infection develop 
neurological symptomatology. SARS-CoV-2 can 
cause a wide range of symptoms from other organic 
systems such as the gastrointestinal tract, manifested 
by diarrhea and vomiting, blood clotting disorders, and 
heart damage [19], [20], [21].
Organ dysfunction can be life-threatening. 
Rapid clinical symptom in pediatric patients infected 
with SARS-CoV-2 and neurological damage may lead 
to endotracheal intubation and placement of this group 
of patients on mechanical ventilation [22], [23], [24].
Case Report
We are presented 9-month-old infant referred 
to our clinic in convulsive status, fever (temperature 
38.2), and disturbed consciousness. From anamnestic 
information, the infant has been febrile for 2 days with 
profuse vomiting initiating just before admission at 
the clinic. Epidemiological survey for COVID-19 was 
a false negative. At the moment of admission in the 
clinic, the infant looked intoxicated with generalized 
tonic-clonic seizures, with shortness of breath and 
fever with a weakened reaction to painful stimuli. It 
was admitted in the isolation unit by the protocol of the 
clinic. The seizures were treated with an intravenous 
benzodiazepine. The test of SARS-CoV-2 was done. 
Laboratory investigationes were made: Complete 
blood count: Hemoglobin = 105 g/l, erythrocytes = 4.45 
× 10*12/l, leukocytes = 10.69 × 10*9/l, thrombocytes 
= 242 × 10*9/l, hematocrit = 31.8%, neutrophils = 
45.5%, lymphocytes = 43.5%; C-reactive protein = 
<0.2 mg/l; glycemia = 13.46 mmol/l; sodium = 133 
mmol/l, potassium = 4.3 mmol/l, calcium = 2.13 mmol/l, 
phosphor = 1.72 mmol/l, magnesium = 0.77 mmol/l, 
chloride = 106 mmol/l; total bilirubin = 1.8 umol/l; 
direct bilirubin = <1.8 umol/l; AST=54 U/L; ALT = 29 
U/L; LDH = 314 U/L; GGT = 10 U/L; creatinine = 41 
umol/l; urea = 3,3 mmol/l; total protein = 56 g/l, albumin 
= 42 g/l; CK= 206 U/L; CKMB = 49.12 U/L; ABS: pH = 
7.38; pCO2 = 34.1 mmHg; pO2 = 90.5 mmHg; HCO3 
= 19.7 mmol/l; BE = −4.9 mmol/l; and sO2 = 96.1%. 
Urinalysis parameters were normal. Due to suspected 
encephalitis, a lumbar puncture was indicated. We 
consult an ophthalmologist who performs fundus 
oculi examination and no changes were detected. We 
perform a lumbar puncture, liquor was obtained under 
pressure, clear, without elements, with proteinuria and 
glycorrhachia. Liquor biochemical analysis: Lactates 
= 1.70 mmol/L, glucose 5.08 mmol/L, and proteins = 
2027 mg/L. Film array meningitis/encephalitis (ME) 
panel was not isolated from the liquor a causative agent. 
From blood culture was isolated Staphylococcus with 
film array blood culture identification panel qualitative 
multiplexed nucleic acid-based in vitro diagnostic test. 
The infant was put on dual antibiotic therapy with third-
generation cephalosporin and aminoglycoside, antiviral 
drug, anticonvulsant drug, and anti-edematous therapy. 
Due to the persistence of convulsive status, a CT scan of 
the brain was performed with the finding of enlargement 
of the lateral ventricles, with intraventricular masses 
and pronounced internal hydrocephalus (Figure 1).
Figure 1: Computed tomography scan of the brain-enlargement of 
the lateral ventricles, with intraventricular masses and pronounced 
internal hydrocephalus
Late that day we have gotten the results of 
SARS-COV-2 from the infant that was positive as well 
as the grandmother that has actually taking care of 
the infant during the past 2 weeks. We have made a 
teleconference with Geneva Children’s Hospital due 
to the fact that the infant had Swiss citizenship. They 
suggested, according to the fact that they might transfer 
the infant in their country and come by fly ambulance, 
but before that to intubate. That actually happened 
immediately after a few minutes with cardiac arrest and 
no breathing. The infant was intubated immediately and 
put on mechanical ventilation SIPPV. After a couple 
of hours, the plane came and the child by all means 
of protocols for COVID-19 pandemic was transferred 
safely in Geneva.
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Discussion
By all means, infants are before getting 
encephalitis due to viral infection. Symptoms of viral 
encephalitis in infants usually start with mild flu-
like symptoms, such as fever, fatigue, weakness, 
headache, and aches in muscles or joints. The 
symptoms can be much more severe and include: 
Seizures, confusion, loss of sensation and paralysis, 
agitation or hallucinations, muscle weakness, loss 
of consciousness, and coma. In young children 
and infants, symptoms, and signs encountered: 
Tense fontanels, poor feeding, irritability, nausea, 
and vomiting [25]. Timely diagnosis and treatment 
are important because it is difficult to predict how 
encephalitis will affect each individual. Given the 
heterogeneity of the disease, epidemiological, 
laboratory, clinical, and radiographic examinations 
are required to make a diagnosis and prepare 
the therapeutical protocol. According to previous 
studies from around the world, more than a third 
of patients with SARS-CoV-2 develop neurological 
symptoms, convulsions, loss of sense of smell and 
taste, hallucinations, disorientation, confusion, 
movement disorders [26], [27], [28]. SARS-CoV-2 
virus can result with: Encephalitis, brain edema, 
stroke, neurological disorder, and Guillain-Barré 
syndrome, where the immune system responds 
to SARS-CoV-2 infection with attacks nerve cells 
that lead to muscle weakness and paralysis [29], 
[30]. Once in the bloodstream, the brain barrier 
replicates and causes neurological involvement. 
Although most patients in the pediatric population 
are asymptomatic or have a mild clinical picture, in 
some of them, the clinical picture may deteriorate 
rapidly and lead to acute respiratory distress or 
respiratory failure. Some pediatric patients could 
occur severe clinical manifestations with myocardial 
injury or heart failure, hypoxic encephalopathy, 
coagulation dysfunction, shock, and acute kidney 
injury. In this case report, the fast-moving of the 
poor child health and aggressive progression of the 
disease with proven SARS CO2 19 virus we were 
absolutely engaged with the information of this child 
as having severe inflammatory reaction SIRS that 
progressively made meningoencephalitis affecting 
all areas of the brain (we could not predict how 
long it has been taken in the child body) because 
of poor information of the family but we suppose 
that it has probably taken longer than 2 days (with 
fever). Encephalitis is something that has made an 
infant in very bad condition and stops circulation 
and breathing [22], [23], [24]. Talking and sharing 
the experience with the colleagues from Swiss, we 
could have expected this to happen and we have 
performed all the procedures, including monitoring 
mechanical ventilation and drug therapy. No any 
specific drug for COVID-19 has been given.
Conclusion
In our study (in this case report study), we 
have presented 9-month-old infant with COVID-
19 encephalitis who was referred to our clinic in 
convulsive status, fever (temperature 38.2), disturbed 
consciousness, severe clinical symptoms, and CT scan 
of the brain with the finding of enlarge lateral ventricles, 
intraventricular masses, and internal hydrocephalus. 
Our case report could suggest that SARS-CoV-2 
infection may cause severe clinical symptoms, 
neurological manifestations, and encephalitis in infants.
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